Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Results From a 16-Week, Multicenter, Randomized, Double-Blind Study

Journal:
Journal of the American Academy of Dermatology
Published:
DOI:
10.1016/j.jaad.2025.08.081
Affiliations:
8
Authors:
9
Go to article
Institutions Authors Share
Incyte, United States of America (USA)
3.000000
 0.33
Incyte Biosciences International Sàrl, Switzerland
1.000000
 0.11
Henry Ford Health System (HFHS), United States of America (USA)
1.000000
 0.11
Dermatology Research Institute, Canada
1.000000
 0.11
Fachklinik Bad Bentheim, Germany
1.000000
 0.11
University of Louisville (UofL), United States of America (USA)
1.000000
 0.11
Probity Medical Research, United States, United States of America (USA)
0.500000
 0.06
Ohio University (Ohio), United States of America (USA)
0.500000
 0.06
Interested in Clinical Sciences?